Literature DB >> 19687248

Susceptibility of urinary tract bacteria to fosfomycin.

Sofia Maraki1, George Samonis, Petros I Rafailidis, Evridiki K Vouloumanou, Emmanuel Mavromanolakis, Matthew E Falagas.   

Abstract

We evaluated the in vitro activity of fosfomycin against urinary isolates in a region in Greece that exhibits considerable antimicrobial resistance by evaluating retrospectively relevant susceptibility data retrieved from the microbiological library of the University Hospital of Heraklion, Crete, Greece. We examined 578 urinary isolates. In total, 516 (89.2%) were susceptible to fosfomycin; 415 isolates were gram negative, and 101 isolates were gram positive. Fosfomycin appears to exhibit good levels of in vitro activity against the examined urinary isolates.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19687248      PMCID： PMC2764175          DOI： 10.1128/AAC.00721-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  37 in total

1.  [Abdominal approach in the surgical treatment of hiatal hernia].

Authors:  W Jedrzejczyk; J Kruszyński; L Kita; J Lojkuć; J Strusiewicz
Journal:  Pol Przegl Chir       Date:  1976-12

2.  In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.

Authors:  M de Cueto; L López; J R Hernández; C Morillo; A Pascual
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Antibiotic prescribing for acute and recurrent cystitis in primary care: a 4 year descriptive study.

Authors:  Laura Galatti; Aurelio Sessa; Giampiero Mazzaglia; Serena Pecchioli; Alessandro Rossi; Claudio Cricelli; Gian Carlo Schito; Giuseppe Nicoletti; Achille P Caputi
Journal:  J Antimicrob Chemother       Date:  2006-01-25       Impact factor: 5.790

Review 4.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 5.  Single-dose treatment of acute cystitis with fosfomycin tromethamine.

Authors:  G E Stein
Journal:  Ann Pharmacother       Date:  1998-02       Impact factor: 3.154

Review 6.  Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.

Authors:  S S Patel; J A Balfour; H M Bryson
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

7.  Urologic diseases in America project: trends in resource use for urinary tract infections in women.

Authors:  Tomas L Griebling
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

8.  [Microbiology of urinary tract infections in ambulatory patients. Therapeutic options in times of high antibiotic resistance].

Authors:  Virginia Arreguín; Margarita Cebada; Jesús I Simón; José Sifuentes-Osornio; Miriam Bobadilla-del Valle; Alejandro E Macías
Journal:  Rev Invest Clin       Date:  2007 Jul-Aug       Impact factor: 1.451

9.  [Acute pyelonephritis: bacteriological data and general course of germ resistance].

Authors:  B Pangon; C Chaplain
Journal:  Pathol Biol (Paris)       Date:  2003-10

10.  Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.

Authors:  M Gobernado; L Valdés; J I Alós; C Garcia-Rey; R Dal-Ré; J García-de-Lomas
Journal:  Rev Esp Quimioter       Date:  2007-06       Impact factor: 1.553
View more
  39 in total

1.  Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China.

Authors:  Jianxia Hou; Xianhui Huang; Yuting Deng; Liangying He; Tong Yang; Zhenling Zeng; Zhangliu Chen; Jian-Hua Liu
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

2.  Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully.

Authors:  Vrushali Patwardhan; Sarman Singh
Journal:  Int Urol Nephrol       Date:  2017-06-14       Impact factor: 2.370

3.  Uropathogen distribution and antimicrobial susceptibility in uncomplicated cystitis in Belgium, a high antibiotics prescribing country: 20-year surveillance.

Authors:  S Heytens; J Boelens; G Claeys; A DeSutter; T Christiaens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-17       Impact factor: 3.267

Review 4.  Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

5.  In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.

Authors:  Andrea Endimiani; Gopi Patel; Kristine M Hujer; Mahesh Swaminathan; Federico Perez; Louis B Rice; Michael R Jacobs; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

6.  Susceptibility of Urinary Tract Bacteria to Newer Antimicrobial Drugs.

Authors:  Manjula Mehta; Jyoti Sharma; Sonia Bhardwaj
Journal:  Open Access Maced J Med Sci       Date:  2016-01-25

7.  Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods.

Authors:  Ching-Lan Lu; Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Lee-Jene Teng; John D Turnidge; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

Review 8.  Fosfomycin: Resurgence of an old companion.

Authors:  Sangeeta Sastry; Yohei Doi
Journal:  J Infect Chemother       Date:  2016-02-28       Impact factor: 2.211

Review 9.  Clinical management of infections caused by multidrug-resistant Enterobacteriaceae.

Authors:  Mercedes Delgado-Valverde; Jesús Sojo-Dorado; Alvaro Pascual; Jesús Rodríguez-Baño
Journal:  Ther Adv Infect Dis       Date:  2013-04

10.  Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods.

Authors:  L V Perdigão-Neto; M S Oliveira; C F Rizek; C M D M Carrilho; S F Costa; A S Levin
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.